These data suggest that in clinical investigations of early revascularization among patients with NSTEMI, extended follow-up may be necessary to demonstrate treatment benefit.
这些资料提示在NSTEMI患者的早期再血管化的临床研究中，延长随访时间对于验证治疗获益是必要的。
The main surgical treatment is the revascularization operation.
外科治疗主要为血管重建手术。
Method:Reading the literature about revascularization and then summarizing them.
方法：阅读关于血管新生方面的文献，进行总结；
This article reviews the present application situation of the revascularization.
文章就脑血运重建术的应用现状进行综述。
Results 41 patients underwent revascularization and 29 patients by medical treatment.
结果41例患者接受血运重建术，29例患者接受内科保守治疗。
Objective to observe the effect of revascularization on total coronary artery occlusion.
目的分析冠状动脉完全闭塞后介入治疗的技术及疗效。
No cerebrovascular event occurred in the 6 patients who underwent surgical revascularization.
而6例行血管成形术患者中无一例发生脑血管事件。
As the time to revascularization therapy increased, the stroke risk also rose, the report indicates.
该研究报告称随着血管再灌注时间的延长，脑中风的危险性也增加。
International Circulation: Another new point is the timing of revascularization. How has that changed?
《国际循环》：另一个新问题是血运重建的时间，这将如何改变呢？
Marked proliferation of the vessels was present both in the flap and recipient bed in revascularization.
皮瓣和受区的血管都经历了一个明显的增生过程。
What is the evidence of long term benefit of hybrid revascularization for complex coronary artery disease?
当前杂交再血管化治疗复杂冠脉疾病治疗的长期获益证据有哪些？
Objective To evaluate the cardiac angiogenesis after percutaneous myocardial laser revascularization (PMR).
目的探讨经皮激光心肌血运重建术（PMR）治疗心肌缺血的机制。
It was suggested that the vessel growth from host to the graft is one of the main patterns of revascularization.
表明，宿主软组织血管直接长入移植骨为再血管化的主要模式之一。
Early revascularization was associated with a similar improvement in long-term outcomes for both STEMI and NSTEMI.
早期再血管化在改善STEMI和NSTEMI的长期结果方面结果相似。
The primary end point was the rate of death, nonfatal myocardial infarction, and repeat revascularization at 1 year.
主要终点为术后1年的死亡、非致死性心肌梗死和再次再血管化。
Promoting revascularization in ischemic myocardium has been a novel therapeutic strategy for ischemic cardiovascular diseases.
促进缺血心肌血管新生已成为治疗缺血性心血管疾病的新策略。
Could you share your experience with us in which revascularization approach such as DES PCI or CABG is better for which patients?
能否分享在哪些患者适用何种血运重建(如药物支架PCI介入或冠脉搭桥)方面的经验？
All stents were placed to relieve his angina, refractory to maximal medical treatment and transmyocardial laser revascularization.
所有的支架的植入均是为了缓解药物治疗欠佳的难治性心绞痛症状。
The timing and type of coronary revascularization may play a role in the stroke risk, but until now no studies have looked at this.
心肌梗死以后血管再通的时间和方式对脑中风的危险性具有一定影响。直到最近还没有研究关注这一方面。
When asked by the pharmacist, TT admits to having undergone coronary revascularization about 2 months ago after a bout of chest pain.
当接受药师询问的时候，TT承认大约2个月前在一次胸痛发作后，她进行了冠脉重建术。
Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization.
复合终点为初次致命或非致命性冠状动脉事件、卒中和血管重建。
Objective To evaluate the clinical effects of graft bypass in arterial revascularization for severe ischemia of lower extremities(ILE).
目的探讨人工血管旁路搭桥手术治疗下肢严重动脉缺血的效果。
Objective To compare the clinical feature and revascularization status in the aged with different types of acute myocardial infarction.
目的探讨不同类型老年急性心肌梗死患者的临床特点及血运重建状况。
Objective to observe the clinical efficacy of percutaneous laser myocardial revascularization (PLMR) on the treatment of angina pectoris.
观察经皮激光打孔心肌血运重建术治疗顽固性心绞痛的临床疗效。
The primary end point was defined as cardiac mortality, Q-wave myocardial infarction (MI), or refractory angina requiring revascularization.
主要终点事件包括心脏性死亡、Q波性心梗、再发心绞痛需要再次血运重建等。
Objective: To establish an animal model of microwave hyperthermic devitalization of long bones, and observe the process of revascularization.
目的：建立长骨微波高温灭活的动物模型，并观察其再血管化过程。
ResultsFor follow-up 47 patients, the mortality, target vessel revascularization ratio and major adverse cardiac events were 2.1%, 2.1%, 6.4%.
结果对47例患者进行随访，病死率、靶血管重建率和主要心脏事件发生率分别为2.1%、2.1%和6.4%。
ResultsFor follow-up 47 patients, the mortality, target vessel revascularization ratio and major adverse cardiac events were 2.1%, 2.1%, 6.4%.
结果对47例患者进行随访，病死率、靶血管重建率和主要心脏事件发生率分别为2.1%、2.1%和6.4%。
应用推荐